04
Aug
Minimal Critical Region and Genes for a Typical Presentation of Langer-Giedion Syndrome
0 Comment
Though Langer-Giedion Syndrome (LGS) is described as a chromosomal disorder caused by a deletion at 8q23q24 which encompasses genes TRPS1, EXT1, and RAD21, there remains to be a strong genotype-phenotype correlation because molecular genetic testing of LGS patients is not often reported in literature. The authors report two unrelated patients... Read More
30
Jul
9p13.2 deletion, the PAX5 gene and the brain
9p13.2 and the PAX5 gene. Mutation or deletion of this gene causes a novel neurodevelopmental disorder. The clinical consequences of deletions of the distal part of 9p are well known. At the same time the significance of interstitial deletions of other areas of 9p are not so clear. The segment... Read More
30
Jul
8q12.3 deletion, the YTHDF3 gene and normal brain development
The YTHDF3 gene is located at chromosome 8q12.3 deletion. The data demonstrates that this gene is necessary for normal brain development. In animal models the YTHDF3 gene is necessary for normal development of the brain. However this gene has not been shown to cause any Mendelian disease. In humans, the... Read More
29
Jul
Phelan-McDermid syndrome and new treatment medications
Phelan-McDermid syndrome new treatments may improve some patients’ symptoms – more research necessary. Phelan-McDermid syndrome (PMS) is a disorder caused by deletions of the distal segment of 22q (22q13.3). The main factor in this condition is haploinsufficiency of the SHANK3 gene located at this segment. Mutations of this gene produce... Read More
29
Jul
10p12.1 deletion and the WAC gene
Chromosome 10p12.1 deletion and the affect of the WAC gene The short arm of chromosome 10 contains the WAC gene, located at 10p12.1. A loss of function of this gene causes DeSanto-Shinawi syndrome (DESSH) which is characterized by facial dysmorphism, global developmental delay and behavioral abnormalities. Patients with deletions... Read More
